Positron Emission Tomography (PET) is an imaging method that works by tracking sugar uptake in both healthy and abnormal cells in the body. It enables radiologists to see body function (cell activity) and identify areas that are absorbing sugar. To determine the tissues that absorb high amounts of sugar, the patient is injected with a
The total body dynamic PET scans could be used to detect metastatic cancer successfully. Dynamic PET provides parametric images showing the actual behavior of the tissue. The parametric images can potentially help to detect lesions and evaluate the response of cancer to therapy.But this potential has not been within the clinic, as conventional PET scanners don’t
Lung cancer is caused by many factors, the most common being smoking. But now there’s good news for people at risk of the disease. A low-dose CT scan can help save their lives. Low dose CT scans, together with follow-up PET scans, can help remove nodules in the lungs early before they grow and progress.
Patients with total metabolic response on FDG-PET scan should get consideration with complete response. Those with a partial response on a CT scan and a complete metabolic response on FDG-PET scan should be considered to have achieved a low risk for melanoma relapse and complete response. Patients with metastatic melanoma treated with anti-PD1 immune checkpoint
Diagnosing and tracking tumors in patients with neuroendocrine cancer is quite challenging. However, a new pharmaceutical drug was approved for use with positron emission tomography (PET) to make rare tumors visible on medical imaging. Known as Gallium-68, or NETSpot, or Gallium Dotatate, the drug is used in PET-CT imaging of neuroendocrine tumors. PET scanning helps